Psychemedics Corporation
PMDI
$2.30
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 20.26M | 20.79M | 21.60M | 22.10M | 22.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.26M | 20.79M | 21.60M | 22.10M | 22.80M |
| Cost of Revenue | 12.49M | 12.96M | 13.27M | 13.69M | 14.20M |
| Gross Profit | 7.77M | 7.82M | 8.33M | 8.41M | 8.60M |
| SG&A Expenses | 9.85M | 10.31M | 10.23M | 10.19M | 9.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.19M | 24.23M | 24.56M | 25.02M | 25.21M |
| Operating Income | -2.93M | -3.44M | -2.96M | -2.92M | -2.41M |
| Income Before Tax | -2.95M | -3.45M | -3.48M | -3.44M | -2.92M |
| Income Tax Expenses | 43.00K | 1.11M | 981.00K | 716.00K | 973.00K |
| Earnings from Continuing Operations | -3.00 | -4.56 | -4.46 | -4.15 | -3.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.00M | -4.56M | -4.46M | -4.15M | -3.90M |
| EBIT | -2.93M | -3.44M | -2.96M | -2.92M | -2.41M |
| EBITDA | -1.89M | -2.24M | -1.60M | -1.40M | -827.00K |
| EPS Basic | -0.51 | -0.79 | -0.77 | -0.72 | -0.68 |
| Normalized Basic EPS | -0.32 | -0.37 | -0.32 | -0.32 | -0.26 |
| EPS Diluted | -0.51 | -0.79 | -0.77 | -0.72 | -0.68 |
| Normalized Diluted EPS | -0.32 | -0.37 | -0.32 | -0.32 | -0.26 |
| Average Basic Shares Outstanding | 23.32M | 23.18M | 23.08M | 22.96M | 22.82M |
| Average Diluted Shares Outstanding | 23.32M | 23.18M | 23.08M | 22.96M | 22.82M |
| Dividend Per Share | 0.00 | 0.00 | 0.00 | 0.07 | 0.14 |
| Payout Ratio | 0.00% | 0.00% | -17.92% | -19.23% | -30.74% |
